Sionna Therapeutics (SION) Misses Q2 EPS by 14c
Tweet
Share
E-mailGet Alerts SION Hot Sheet
Join SI Premium – FREE
Sionna Therapeutics (NASDAQ: SION) reported Q2 EPS of ($0.66), $0.14 worse than the analyst estimate of ($0.52).
For earnings history and earnings-related data on Sionna Therapeutics (SION) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Wolverine World Wide (WWW) Tops Q2 EPS by 2c; offers guidance
- Coherent (COHR) PT Raised to $420 at Needham
- Cantor Fitzgerald Downgrades Better Home & Finance Holding (BETR) to Neutral
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
